Insider Trading April 15, 2026 06:11 PM

Beyond Meat CFO Executes $253K Stock Sale Amid Operational Updates and Analyst Cuts

Lubi Kutua sold shares under a 10b5-1 plan as the company advances retail distribution and secures pea protein supply

By Hana Yamamoto BYND
Beyond Meat CFO Executes $253K Stock Sale Amid Operational Updates and Analyst Cuts
BYND

Beyond Meat Chief Financial Officer Lubi Kutua disclosed the sale of 419,042 shares on April 13, 2026, generating $253,310 in proceeds under a Rule 10b5-1 plan. Kutua also sold a smaller block to cover taxes tied to restricted stock unit vesting. The transactions come alongside company developments including a nationwide rollout of reformulated breakfast sausage, a multi-year pea protein supply agreement, the filing of a delayed fiscal 2025 annual report, and analyst price-target reductions.

Key Points

  • CFO Lubi Kutua sold 419,042 shares on April 13, 2026 under a Rule 10b5-1 plan, generating $253,310; an additional 1,208 shares were sold to cover tax obligations totaling $797.
  • Beyond Meat has launched a nationwide rollout of a reformulated Beyond Breakfast Sausage at major retailers and secured a multi-year pea protein supply agreement with Roquette Frres for 2026-2027.
  • Analysts have reduced price targets following fiscal 2025 results and weak guidance - TD Cowen to $0.60 (Sell) and Mizuho to $0.50 - while InvestingPro flags overvaluation, significant debt, and cash burn concerns.

Insider transaction details

Beyond Meat Inc. (NASDAQ: BYND) Chief Financial Officer Lubi Kutua reported the sale of 419,042 shares of common stock on April 13, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares changed hands at prices between $0.588 and $0.6173, producing total gross proceeds of $253,310.

The filing notes that the disposition was executed pursuant to a Rule 10b5-1 trading plan that Kutua adopted on December 12, 2025.

On the same date, Kutua also transferred 1,208 shares to satisfy tax obligations tied to the vesting of restricted stock units. That smaller sale occurred at $0.66 per share and totaled $797.


Post-transaction holdings

Following these moves, Kutua directly holds 5,749,967 shares of Beyond Meat common stock, which includes 57,366 restricted stock units.


Share performance and valuation signals

The insider sale coincides with a challenging period for Beyond Meat shares, which have fallen approximately 70% over the past year. The stock, however, has exhibited a short-term rebound, gaining about 25% over the most recent week.

According to InvestingPro analysis cited in the filing, the stock presently appears overvalued relative to its Fair Value. The platform's Pro Research Report highlights specific concerns about the company's heavy debt load and ongoing cash burn.


Operational and corporate developments

Beyond Meat has announced the nationwide roll-out of a reformulated Beyond Breakfast Sausage lineup. The product is set to be distributed at major grocery chains including Kroger and Sprouts Farmers Market, with plans for availability at Whole Foods Market.

The company also resolved a Nasdaq listing compliance matter by filing its delayed annual report for fiscal year 2025.

On the supply front, Beyond Meat entered a multi-year sales agreement with Roquette Frres to secure pea protein for 2026 and 2027. The arrangement includes adjustment mechanisms tied to forecasted requirements.


Analyst updates

Following fourth-quarter fiscal 2025 results and forward guidance, TD Cowen reduced its price target for Beyond Meat to $0.60 while maintaining a Sell rating. Mizuho also lowered its target to $0.50, citing weak first-quarter revenue guidance that was significantly below consensus expectations.


Context and implications

The disclosed insider sale, coupled with recent analyst downgrades and the InvestingPro valuation assessment, provides market participants with contemporaneous data points on executive liquidity actions and external perspectives on the company's financial position. At the same time, the retail rollout and secured pea protein supply represent operational initiatives aimed at bolstering distribution and ingredient continuity.

Investors and market observers will likely weigh these cross-cutting signals - insider selling, valuation concerns, analyst revisions, and operational progress - as they assess the company's near-term prospects.

Risks

  • Valuation risk - InvestingPro analysis indicates the stock appears overvalued relative to Fair Value, raising downside risk for equity holders - impacts equity investors and markets.
  • Balance-sheet and liquidity risk - the company's significant debt burden and ongoing cash burn highlighted in Pro Research may constrain strategic flexibility - impacts creditors and the packaged-foods sector.
  • Revenue and guidance risk - weaker-than-expected revenue guidance that prompted analyst price-target reductions suggests demand or execution shortfalls could continue - impacts consumer staples and retail distribution partners.

More from Insider Trading

Photronics Director Sells $225,000 in Stock After Exercising Options; Company Posts Quarterly Beat and Advances Mask Capability Apr 15, 2026 Genprex Director Disposes of Small Holding as Company Advances Gene Therapy IP and Data Presentations Apr 15, 2026 Arista CEO Jayshree Ullal Sells $16.9M in ANET Stock Under 10b5-1 Plan Apr 15, 2026 Oruka Therapeutics CMO Disposes $462,829 in Stock as Analysts Lift Targets on ORKA-001 Progress Apr 15, 2026 GameStop General Counsel Disposes of $90.7K in GME Shares Under 10b5-1 Plan Apr 15, 2026